NIKA PHARMACEUTICALS, INC
NIKA · OTCMCIK 1145604fmd_009SJ3E14M6XHA40B8B0SX84R1Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 25 periods
Latest annual · FY2024
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
Latest quarter · Q3 FY2026
Millions- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- n/m
- Net income, 5 yearsFY2020 to FY2025
- n/m
NIKA PHARMACEUTICALS, INC (NIKA) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$76,398 | -$95,792 | 10-K 2026-03-25 · proof | |
| Net income | -$76,398 | -$95,792 | 10-K 2026-03-25 · proof | |
| Cash from operating activities | -$79,654 | -$154,932 | 10-K 2026-03-25 · proof | |
| Total assets | $20,996 | $17,934 | +17.1% | 10-K 2026-03-25 · proof |
| Total liabilities | $318,624 | $239,164 | +33.2% | 10-K 2026-03-25 · proof |
| Cash and cash equivalents | $1,889 | $2,083 | -9.3% | 10-K 2026-03-25 · proof |
- What was NIKA PHARMACEUTICALS, INC (NIKA)'s operating income in fiscal 2025?
- NIKA PHARMACEUTICALS, INC (NIKA) reported operating income of -$76,398 for fiscal 2025 (the year ended Dec 31, 2025), against -$95,792 the year before. Source: the 10-K filed with the SEC on Mar 25, 2026. SEC
- What was NIKA PHARMACEUTICALS, INC (NIKA)'s net income in fiscal 2025?
- NIKA PHARMACEUTICALS, INC (NIKA) reported net income of -$76,398 for fiscal 2025 (the year ended Dec 31, 2025), against -$95,792 the year before. Source: the 10-K filed with the SEC on Mar 25, 2026. SEC
- What was NIKA PHARMACEUTICALS, INC (NIKA)'s cash from operating activities in fiscal 2025?
- NIKA PHARMACEUTICALS, INC (NIKA) reported cash from operating activities of -$79,654 for fiscal 2025 (the year ended Dec 31, 2025), against -$154,932 the year before. Source: the 10-K filed with the SEC on Mar 25, 2026. SEC
- What are NIKA PHARMACEUTICALS, INC (NIKA)'s total assets?
- As of Dec 31, 2025, NIKA PHARMACEUTICALS, INC (NIKA) reported total assets of $20,996, against $17,934 a year earlier (+17.1%). Source: the 10-K filed with the SEC on Mar 25, 2026. SEC
- What are NIKA PHARMACEUTICALS, INC (NIKA)'s total liabilities?
- As of Dec 31, 2025, NIKA PHARMACEUTICALS, INC (NIKA) reported total liabilities of $318,624, against $239,164 a year earlier (+33.2%). Source: the 10-K filed with the SEC on Mar 25, 2026. SEC
- What are NIKA PHARMACEUTICALS, INC (NIKA)'s cash and cash equivalents?
- As of Dec 31, 2025, NIKA PHARMACEUTICALS, INC (NIKA) reported cash and cash equivalents of $1,889, against $2,083 a year earlier (-9.3%). Source: the 10-K filed with the SEC on Mar 25, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:NIKA&period_type=annual&limit=5"Information only, not investment advice.